Literature DB >> 17716971

Differential regulation of vitamin D receptor (VDR) by the p53 Family: p73-dependent induction of VDR upon DNA damage.

Ramakrishna Kommagani1, Vandana Payal, Madhavi P Kadakia.   

Abstract

p63 and p73, members of the p53 family, have been shown to be functionally distinct from p53. Vitamin D receptor (VDR) is a ligand (vitamin D(3))-dependent transcription factor, which is shown to play a major role in calcium homeostasis and keratinocyte differentiation. Vitamin D and its analogues in combination with DNA-damaging agents are extensively used for cancer chemotherapy. In this report, we examined whether p53 affects p63-mediated induction of VDR and studied the effect of DNA damage on VDR induction in p53 null cell lines. Our results demonstrate that p53 itself does not induce VDR expression, nor does it affect p63-mediated VDR induction in the cell lines tested in this study. Furthermore, we observed p53-independent activation of VDR upon DNA damage and associated the induction of VDR to p73. We have demonstrated that ectopic expression of various p73 isoforms can induce VDR expression. Inhibition of p73 in cells treated with DNA-damaging agents exhibited decreased VDR expression. Finally, we show that upon DNA damage, induction of VDR sensitizes the cells to vitamin D treatment. In conclusion, our results indicate that VDR is regulated by p63 and p73 and that the induction of VDR expression upon DNA damage is p73-dependent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716971      PMCID: PMC2771332          DOI: 10.1074/jbc.M703641200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Etoposide stimulates 1,25-dihydroxyvitamin D3 differentiation activity, hormone binding and hormone receptor expression in HL-60 human promyelocytic cells.

Authors:  R Torres; C Calle; P Aller; F Mata
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

2.  p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.

Authors:  Marshall Urist; Tomoaki Tanaka; Masha V Poyurovsky; Carol Prives
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

Review 3.  Structural basis for gene activation by p53 family members.

Authors:  Ariane Scoumanne; Kelly Lynn Harms; Xinbin Chen
Journal:  Cancer Biol Ther       Date:  2005-11-18       Impact factor: 4.742

Review 4.  p73, a sophisticated p53 family member in the cancer world.

Authors:  Toshinori Ozaki; Akira Nakagawara
Journal:  Cancer Sci       Date:  2005-11       Impact factor: 6.716

Review 5.  Vitamin D and cancer: an update of in vitro and in vivo data.

Authors:  Paloma Ordonez-Moran; Maria Jesus Larriba; Natalia Pendas-Franco; Oscar Aguilera; Jose Manuel Gonzalez-Sancho; Alberto Munoz
Journal:  Front Biosci       Date:  2005-09-01

6.  TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria.

Authors:  Olav Gressner; Tobias Schilling; Katja Lorenz; Elisa Schulze Schleithoff; Andreas Koch; Henning Schulze-Bergkamen; Anna Maria Lena; Eleonora Candi; Alessandro Terrinoni; Maria Valeria Catani; Moshe Oren; Gerry Melino; Peter H Krammer; Wolfgang Stremmel; Martina Müller
Journal:  EMBO J       Date:  2005-06-09       Impact factor: 11.598

7.  DeltaNp63alpha up-regulates the Hsp70 gene in human cancer.

Authors:  Guojun Wu; Motonobu Osada; Zhongmin Guo; Alexey Fomenkov; Shahnaz Begum; Ming Zhao; Sunil Upadhyay; Mingzhao Xing; Feng Wu; Chulso Moon; William H Westra; Wayne M Koch; Roberto Mantovani; Joseph A Califano; Edward Ratovitski; David Sidransky; Barry Trink
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

8.  Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation.

Authors:  Reo Maruyama; Fumio Aoki; Minoru Toyota; Yasushi Sasaki; Hirofumi Akashi; Hiroaki Mita; Hiromu Suzuki; Kimishige Akino; Mutsumi Ohe-Toyota; Yumiko Maruyama; Haruyuki Tatsumi; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

9.  Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation.

Authors:  Claire M Banwell; Rena Singh; Paul M Stewart; Milan R Uskokovic; Moray J Campbell
Journal:  Recent Results Cancer Res       Date:  2003

10.  Identification of vitamin D receptor as a target of p63.

Authors:  R Kommagani; T M Caserta; M P Kadakia
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

View more
  15 in total

1.  BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents.

Authors:  Xuening Wang; Jonathan S Harrison; George P Studzinski
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-13       Impact factor: 4.292

2.  Vitamin D directly regulates Mdm2 gene expression in osteoblasts.

Authors:  Hankui Chen; Grant Reed; Janete Guardia; Sandeep Lakhan; Oliver Couture; Emily Hays; Nalini Chandar
Journal:  Biochem Biophys Res Commun       Date:  2012-11-10       Impact factor: 3.575

3.  MDM2 binds and inhibits vitamin D receptor.

Authors:  Kristina Heyne; Tessa-Carina Heil; Birgit Bette; Jörg Reichrath; Klaus Roemer
Journal:  Cell Cycle       Date:  2015-05-13       Impact factor: 4.534

4.  A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells.

Authors:  V Bhattacharjee; Y Zhou; T J Yen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Modulation of the vitamin D3 response by cancer-associated mutant p53.

Authors:  Perry Stambolsky; Yuval Tabach; Giulia Fontemaggi; Lilach Weisz; Revital Maor-Aloni; Zehava Siegfried; Zahava Sigfried; Idit Shiff; Ira Kogan; Moshe Shay; Eyal Kalo; Giovanni Blandino; Itamar Simon; Moshe Oren; Varda Rotter
Journal:  Cancer Cell       Date:  2010-03-16       Impact factor: 31.743

6.  Regulation of VDR by deltaNp63alpha is associated with inhibition of cell invasion.

Authors:  Ramakrishna Kommagani; Mary K Leonard; Stefanie Lewis; Rose-Anne Romano; Satrajit Sinha; Madhavi P Kadakia
Journal:  J Cell Sci       Date:  2009-07-21       Impact factor: 5.285

7.  Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway.

Authors:  Carly M Kemmis; JoEllen Welsh
Journal:  J Cell Biochem       Date:  2008-11-01       Impact factor: 4.429

8.  p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3.

Authors:  Sabine Hünten; Heiko Hermeking
Journal:  Oncotarget       Date:  2015-06-30

9.  p73 is essential for vitamin D-mediated osteoblastic differentiation.

Authors:  R Kommagani; A Whitlatch; M K Leonard; M P Kadakia
Journal:  Cell Death Differ       Date:  2009-09-25       Impact factor: 15.828

Review 10.  Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling.

Authors:  Jörg Reichrath; Sandra Reichrath; Kristina Heyne; Thomas Vogt; Klaus Roemer
Journal:  Front Physiol       Date:  2014-06-03       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.